| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/27/2009 | US20090215050 Systems and methods for point-of-care amplification and detection of polynucleotides |
| 08/27/2009 | US20090215049 Novel litaf binding site peptides and methods of using the same |
| 08/27/2009 | US20090215048 Method of in-silico improvement of organisms using the flux sum of metabolites |
| 08/27/2009 | US20090215047 Methods of Detecting Viability-Associated Molecules |
| 08/27/2009 | US20090215046 Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer |
| 08/27/2009 | US20090215045 identifying a human subject having increased or decreased sensitivity to warfarin, by detecting the presence of a single nucleotide polymorphism in the vitamin K epoxide reductase (VKOR) gene |
| 08/27/2009 | US20090215044 Receptor in Dendritic Cells |
| 08/27/2009 | US20090215043 Polymorphic GHSR Nucleic Acids And Uses Thereof |
| 08/27/2009 | US20090215042 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 08/27/2009 | US20090215041 Multiple snp for diagnosing colorectal cancer, microarray and kit comprising the same, and method of diagnosing colorectal cancer using the same |
| 08/27/2009 | US20090215040 Human autism susceptibility gene encoding a transmembrane protein and uses thereof |
| 08/27/2009 | US20090215039 Investigations |
| 08/27/2009 | US20090215038 Prediction of Metastasis |
| 08/27/2009 | US20090215037 Dynamically expressed genes with reduced redundancy |
| 08/27/2009 | US20090215036 Genetic Alterations Useful For The Response Prediction of Malignant Neoplasia to Taxane-Based Medical Treatments |
| 08/27/2009 | US20090215035 Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method |
| 08/27/2009 | US20090215034 Method for selectively detecting subsets of nucleic acid molecules |
| 08/27/2009 | US20090215033 Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with Neuroblastoma |
| 08/27/2009 | US20090215032 Nucleic acid comprising a non-specific spacer sequence, an identifier sequence, and an analyte capture sequence bound to an analyte adaptor compound that is covalently bound to an antibody or an antigen-binding antibody fragment; Multiplexing |
| 08/27/2009 | US20090215031 Mutants of mycobacteria and process thereof |
| 08/27/2009 | US20090215030 Method |
| 08/27/2009 | US20090215029 Methods of isolating and purifying nucleic acid-binding biomolecules and compositions including same |
| 08/27/2009 | US20090215028 Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV |
| 08/27/2009 | US20090215027 Method and system for colorimetric determination of a chemical or physical property of a turbid medium |
| 08/27/2009 | US20090215026 Method for storing tetrazolium compound, stabilizer used in the same, and tetrazolium compound reagent solution using the method |
| 08/27/2009 | US20090215025 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 08/27/2009 | US20090215024 Biomarkers upregulated in prostate cancer |
| 08/27/2009 | US20090215023 High temperature flow-through device for rapid solubilization and analysis |
| 08/27/2009 | US20090214671 Personalizing Cancer Chemotherapy Based on Methylation and Germ-Line Mutational Analysis of BRCA-1 |
| 08/27/2009 | US20090214663 Virus coated nanoparticles and uses thereof |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/27/2009 | US20090214583 Epitope-enhancement of a human cd4 hiv epitope |
| 08/27/2009 | US20090214582 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof |
| 08/27/2009 | US20090214574 Anti-cd16 binding molecules |
| 08/27/2009 | US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 08/27/2009 | US20090214571 Colon cancer related gene tom34 |
| 08/27/2009 | US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases |
| 08/27/2009 | US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/27/2009 | US20090214548 TGR3-Like Protein Receptor |
| 08/27/2009 | US20090214546 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214542 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214536 CACNA1E in Cancer Diagnosis, Detection and Treatment |
| 08/27/2009 | US20090214531 Methods and Compositions for Treating and Preventing Bacterial Infections |
| 08/27/2009 | US20090214524 Methods and compositions for regulating cell cycle checkpoints |
| 08/27/2009 | US20090214518 Methods and compositions for treating solid tumors and enhancing tumor vaccines |
| 08/27/2009 | US20090214516 Inhibitors of Reglll Proteins as Asthma Therapeutics |
| 08/27/2009 | US20090214514 Gus3 neuropeptides for regulating hypothalamic function |
| 08/27/2009 | US20090214507 Method of treating preventing, inhibiting or reducing damage to cardiac tissue |
| 08/27/2009 | US20090214494 Cancer Vaccines and Therapeutic Methods |
| 08/27/2009 | US20090214490 Human embryonic stem cell methods and podxl expression |
| 08/27/2009 | US20090214486 Serum Response Factor and Myocardin Control Alzheimer Cerebral Amyloid Angiopathy |
| 08/27/2009 | US20090214483 Progenitor Cells and Uses Thereof |
| 08/27/2009 | US20090214477 Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis |
| 08/27/2009 | US20090214476 Novel mannose-specific adhesins and their use |
| 08/27/2009 | US20090214465 Quinoxaline Derivatives as Antitumor Agents |
| 08/27/2009 | US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof |
| 08/27/2009 | US20090214435 Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof |
| 08/27/2009 | US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof |
| 08/27/2009 | US20090214428 Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 08/27/2009 | US20090214425 Tumor therapy with replication competent sindbis viral vectors |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 08/27/2009 | US20090214420 Method of Diagnosis and Treatment and Agents Useful for Same |
| 08/27/2009 | DE102008010584A1 Detecting anaerobic microorganisms capable of degrading aromatic compounds comprises using nucleotide sequences coding for a conserved amino acid sequence of 6-oxocyclohexene-1-carbonyl coenzyme A hydrolase |
| 08/27/2009 | DE10155600B4 Nukleinsäure-Array Nucleic acid array |
| 08/27/2009 | DE10034578B4 Biosensoren, Verfahren zu ihrer Herstellung und ihre Verwendung Biosensors, methods for their preparation and their use |
| 08/27/2009 | CA2752838A1 Cell processing and/or enrichment methods |
| 08/27/2009 | CA2723490A1 Methods and compositions for predicting success in addictive substance cessation and for predicting a risk of addiction |
| 08/27/2009 | CA2721718A1 Stabilization of dehydrogenases with stable coenzymes |
| 08/27/2009 | CA2717690A1 Brca1 mrna expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy |
| 08/27/2009 | CA2717670A1 Brca1 mrna expression predicts survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy |
| 08/27/2009 | CA2716375A1 Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatmemt of autism |
| 08/27/2009 | CA2716368A1 Genetic polymorphisms associated with stroke, methods of detection and uses thereof |
| 08/27/2009 | CA2716049A1 Methods and compositions for diagnosis of age-related macular degeneration |
| 08/27/2009 | CA2715890A1 Kits, solid supports and methods for point-of-care amplification and detection of polynucleotides |
| 08/27/2009 | CA2715774A1 Detection and prognosis of lung cancer |
| 08/27/2009 | CA2715569A1 Systems and methods for identifying a culture as positive for microorganisms with high confidence |
| 08/27/2009 | CA2715566A1 Systems and methods for presumptive identification of microorganism type in a culture |
| 08/27/2009 | CA2715396A1 Compositions and methods for detection of propionibacterium acnes nucleic acid |
| 08/27/2009 | CA2714713A1 Identification of pediatric onset inflammatory bowel disease loci and methods of use thereof for the diagnosis and treatment of the same |
| 08/27/2009 | CA2713872A1 Methods and compositions related to peptides and proteins with c-terminal elements |
| 08/27/2009 | CA2713645A1 Slit2 cancer markers |
| 08/27/2009 | CA2713421A1 Covalently linked thermostable kinase for decontamination process validation |
| 08/27/2009 | CA2684875A1 Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays |
| 08/26/2009 | EP2093568A1 Brca1 mRNA expression predicts survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy |
| 08/26/2009 | EP2093567A1 Brca1 mRNA expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy |
| 08/26/2009 | EP2093566A1 Method for the prognosis of non-small cell lung cancer |
| 08/26/2009 | EP2093565A2 Substrates, devices, and methods for cellular assays |
| 08/26/2009 | EP2093298A2 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Futrins (R-Spondins) |
| 08/26/2009 | EP2093297A2 Agents for treatment or prevention of an allergic disorder |
| 08/26/2009 | EP2093296A2 Electrode with thin working layer |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093292A2 Inhibition of specific histone deacetylase isoforms |
| 08/26/2009 | EP2093288A1 Novel dipeptide-digesting enzyme, method of producing the same, method of assaying glycated protein by using the dipeptide-digesting enzyme and reagent composition to be used therein |
| 08/26/2009 | EP2093286A1 Multi-chain eukaryotic display vectors and uses thereof |
| 08/26/2009 | EP2093284A1 Stabilisation of dehydrogenases with stable coenzymes |
| 08/26/2009 | EP2093233A1 Novel compositions and methods in cancer |
| 08/26/2009 | EP2093194A1 Fluorescent labeling agent and fluorescent labeling method |
| 08/26/2009 | EP2092939A2 Therapeutical use of antibody inducing the production of cytokines |